AVALO THERAPEUTICS INC (AVTX) Stock Analyst Ratings
NASDAQ:AVTX - Nasdaq - US05338F3064 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to AVTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.66. This target is 298.82% above the current price.
AVTX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about AVTX.
In the previous month the buy percentage consensus was at a similar level.
AVTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-19 | BTIG | Initiate | Buy |
| 2024-12-17 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2024-10-24 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-04-16 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2023-06-27 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-06-27 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2023-05-10 | RBC Capital | Maintains | Outperform |
| 2023-02-08 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-03-03 | RBC Capital | Maintains | Outperform |
| 2022-03-03 | Jefferies | Downgrade | Buy -> Hold |
| 2021-09-24 | RBC Capital | Initiate | Outperform |